Cancer Vaccine Market By Product Type (Preventive and Therapeutic), By Technology (Vector-based, Molecular-based, and Cell-based), By Application (Cervical Cancer, Prostate Cancer, Bladder Cancer, Lung Cancer, and Others), By Distribution Channel (Government & Organization Supply, Hospitals, and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Published date: Oct 2024
Report ID: 130580
Number of Pages:
Format:

- 1. Executive Summary
  - 1.1. Definition
  - 1.2. Market Snapshot
  - 1.3. Market Overview
  - 1.4. Segment Overview
  - 1.5. Regional Overview
  - 1.6. Competitive Landscape
  - 1.7. Taxonomy
- 2. Global Market Overview
  - 2.1. Global Market Insights and Industry Overview
  - 2.2. Market Dynamics
    2.2.1. Drivers
    2.2.2. Restraints
    2.2.3. Opportunities
    2.2.4. Key Cancer Vaccine Market Trends
  - 2.3. Regulatory Framework
  - 2.4. Opportunity Map Analysis
  - 2.5. Opportunity Orbits
  - 2.6. PESTLE Analysis
  - 2.7. PORTER’S Five Force Analysis
  - 2.8. Drivers & Restraints Impact Analysis
  - 2.9. Value Chain Analysis
    2.9.1. List of Raw Materials Suppliers
    2.9.2. List of Cancer Vaccine Manufacturers
    2.9.3. List of Dealer/Distributors
  - 2.10. Regional Market Share and BPS Analysis
  - 2.11. Impact of Macro-economic Factors/Geopolitical Factors
- 3. Global Cancer Vaccine Market Analysis and Forecast, By Segment, 2019-2033
  - 3.1. Key Findings
  - 3.2. Global Cancer Vaccine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2019-2033
  - 3.3. Global Cancer Vaccine Market Attractiveness Analysis, By Product Type
    3.3.1. Preventive
    3.3.1.1. Insights
    3.3.1.2. Key Takeaways
    3.3.2. Therapeutic
    3.3.2.1. Insights
    3.3.2.2. Key Takeaways
  - 3.4. Global Cancer Vaccine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2019-2033
  - 3.5. Global Cancer Vaccine Market Attractiveness Analysis, By Technology
    3.5.1. Vector-based
    3.5.1.1. Insights
    3.5.1.2. Key Takeaways
    3.5.2. Molecular-based
    3.5.2.1. Insights
    3.5.2.2. Key Takeaways
    3.5.3. Cell-based
    3.5.3.1. Insights
    3.5.3.2. Key Takeaways
  - 3.6. Global Cancer Vaccine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2019-2033
  - 3.7. Global Cancer Vaccine Market Attractiveness Analysis, By Application
    3.7.1. Cervical Cancer
    3.7.1.1. Insights
    3.7.1.2. Key Takeaways
    3.7.2. Prostate Cancer
    3.7.2.1. Insights
    3.7.2.2. Key Takeaways
    3.7.3. Bladder Cancer
    3.7.3.1. Insights
    3.7.3.2. Key Takeaways
    3.7.4. Lung Cancer
    3.7.4.1. Insights
    3.7.4.2. Key Takeaways
    3.7.5. Others
    3.7.5.1. Insights
    3.7.5.2. Key Takeaways
  - 3.8. Global Cancer Vaccine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
  - 3.9. Global Cancer Vaccine Market Attractiveness Analysis, By Distribution Channel
    3.9.1. Government & Organization Supply
    3.9.1.1. Insights
    3.9.1.2. Key Takeaways
    3.9.2. Hospitals
    3.9.2.1. Insights
    3.9.2.2. Key Takeaways
    3.9.3. Others
    3.9.3.1. Insights
    3.9.3.2. Key Takeaways
- 4. Global Cancer Vaccine Market Analysis and Forecast, By Region, 2019-2033
  - 4.1. Key Findings
  - 4.2. Global Cancer Vaccine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2019-2033
    4.2.1. North America
    4.2.1.1. Regional Insights
    4.2.2. Europe
    4.2.2.1. Regional Insights
    4.2.3. Asia Pacific
    4.2.3.1. Regional Insights
    4.2.4. Latin America
    4.2.4.1. Regional Insights
    4.2.5. Middle East & Africa
    4.2.5.1. Regional Insights
  - 4.3. Global Cancer Vaccine Market Attractiveness Analysis, By Region
- 5. North America Cancer Vaccine Market Analysis and Forecast, 2019-2033
  - 5.1. Key Findings
  - 5.2. North America Cancer Vaccine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2019-2033
  - 5.3. North America Cancer Vaccine Market Attractiveness Analysis, By Product Type
  - 5.4. North America Cancer Vaccine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2019-2033
  - 5.5. North America Cancer Vaccine Market Attractiveness Analysis, By Technology
  - 5.6. North America Cancer Vaccine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2019-2033
  - 5.7. North America Cancer Vaccine Market Attractiveness Analysis, By Application
  - 5.8. North America Cancer Vaccine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
  - 5.9. North America Cancer Vaccine Market Attractiveness Analysis, By Distribution Channel
  - 5.10. North America Cancer Vaccine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  - 5.11. North America Cancer Vaccine Market Attractiveness Analysis, By Country
    5.11.1. The US
    5.11.2. Canada
- 6. Europe Cancer Vaccine Market Analysis and Forecast, 2019-2033
  - 6.1. Key Findings
  - 6.2. Europe Cancer Vaccine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2019-2033
  - 6.3. Europe Cancer Vaccine Market Attractiveness Analysis, By Product Type
  - 6.4. Europe Cancer Vaccine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2019-2033
  - 6.5. Europe Cancer Vaccine Market Attractiveness Analysis, By Technology
  - 6.6. Europe Cancer Vaccine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2019-2033
  - 6.7. Europe Cancer Vaccine Market Attractiveness Analysis, By Application
  - 6.8. Europe Cancer Vaccine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
  - 6.9. Europe Cancer Vaccine Market Attractiveness Analysis, By Distribution Channel
  - 6.10. Europe Cancer Vaccine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  - 6.11. Europe Cancer Vaccine Market Attractiveness Analysis, By Country
    6.11.1. Germany
    6.11.2. The UK
    6.11.3. France
    6.11.4. Spain
    6.11.5. Italy
    6.11.6. Russia
    6.11.7. Netherland
    6.11.8. Rest of Europe
- 7. Asia Pacific Cancer Vaccine Market Analysis and Forecast, 2019-2033
  - 7.1. Key Findings
  - 7.2. Asia Pacific Cancer Vaccine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2019-2033
  - 7.3. Asia Pacific Cancer Vaccine Market Attractiveness Analysis, By Product Type
  - 7.4. Asia Pacific Cancer Vaccine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2019-2033
  - 7.5. Asia Pacific Cancer Vaccine Market Attractiveness Analysis, By Technology
  - 7.6. Asia Pacific Cancer Vaccine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2019-2033
  - 7.7. Asia Pacific Cancer Vaccine Market Attractiveness Analysis, By Application
  - 7.8. Asia Pacific Cancer Vaccine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
  - 7.9. Asia Pacific Cancer Vaccine Market Attractiveness Analysis, By Distribution Channel
  - 7.10. Asia Pacific Cancer Vaccine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  - 7.11. Asia Pacific Cancer Vaccine Market Attractiveness Analysis, By Country
    7.11.1. China
    7.11.2. Japan
    7.11.3. South Korea
    7.11.4. India
    7.11.5. Australia
    7.11.6. New Zealand
    7.11.7. Singapore
    7.11.8. Thailand
    7.11.9. Vietnam
    7.11.10. Rest of Asia Pacific
- 8. Latin America Cancer Vaccine Market Analysis and Forecast, 2019-2033
  - 8.1. Key Findings
  - 8.2. Latin America Cancer Vaccine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2019-2033
  - 8.3. Latin America Cancer Vaccine Market Attractiveness Analysis, By Product Type
  - 8.4. Latin America Cancer Vaccine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2019-2033
  - 8.5. Latin America Cancer Vaccine Market Attractiveness Analysis, By Technology
  - 8.6. Latin America Cancer Vaccine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2019-2033
  - 8.7. Latin America Cancer Vaccine Market Attractiveness Analysis, By Application
  - 8.8. Latin America Cancer Vaccine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
  - 8.9. Latin America Cancer Vaccine Market Attractiveness Analysis, By Distribution Channel
  - 8.10. Latin America Cancer Vaccine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  - 8.11. Latin America Cancer Vaccine Market Attractiveness Analysis, By Country
    8.11.1. Brazil
    8.11.2. Mexico
    8.11.3. Rest of Latin America
- 9. Middle East & Africa Cancer Vaccine Market Analysis and Forecast, 2019-2033
  - 9.1. Key Findings
  - 9.2. Middle East & Africa Cancer Vaccine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2019-2033
  - 9.3. Middle East & Africa Cancer Vaccine Market Attractiveness Analysis, By Product Type
  - 9.4. Middle East & Africa Cancer Vaccine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2019-2033
  - 9.5. Middle East & Africa Cancer Vaccine Market Attractiveness Analysis, By Technology
  - 9.6. Middle East & Africa Cancer Vaccine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2019-2033
  - 9.7. Middle East & Africa Cancer Vaccine Market Attractiveness Analysis, By Application
  - 9.8. Middle East & Africa Cancer Vaccine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
  - 9.9. Middle East & Africa Cancer Vaccine Market Attractiveness Analysis, By Distribution Channel
  - 9.10. Middle East & Africa Cancer Vaccine Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  - 9.11. Middle East & Africa Cancer Vaccine Market Attractiveness Analysis, By Country
    9.11.1. South Africa
    9.11.2. Saudi Arabia
    9.11.3. UAE
    9.11.4. Rest of Middle East & Africa
- 10. Competitive Landscape & Company Profiles
  - 10.1. Market Competition Scenario Analysis, By Company
    10.1.1. Key Takeaways
  - 10.2. Overview of Major Market Players
  - 10.3. Competitor Landscape
  - 10.4. Strategic Mapping
  - 10.5. Company Life Cycle Analysis
  - 10.6. Company Market Share Analysis
  - 10.7. Company Profiles
    10.7.1. Treos Bio Limited
    10.7.1.1. Company Details
    10.7.1.2. Business Overview
    10.7.1.3. Product Portfolio
    10.7.1.4. Financial Insights
    10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.1.6. SWOT Analysis
    10.7.1.7. Geographic Footprint
    10.7.2. Sanofi
    10.7.2.1. Company Details
    10.7.2.2. Business Overview
    10.7.2.3. Product Portfolio
    10.7.2.4. Financial Insights
    10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.2.6. SWOT Analysis
    10.7.2.7. Geographic Footprint
    10.7.3. Moderna, Inc.
    10.7.3.1. Company Details
    10.7.3.2. Business Overview
    10.7.3.3. Product Portfolio
    10.7.3.4. Financial Insights
    10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.3.6. SWOT Analysis
    10.7.3.7. Geographic Footprint
    10.7.4. Ferring B.V.
    10.7.4.1. Company Details
    10.7.4.2. Business Overview
    10.7.4.3. Product Portfolio
    10.7.4.4. Financial Insights
    10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.4.6. SWOT Analysis
    10.7.4.7. Geographic Footprint
    10.7.5. Dynavax Technologies
    10.7.5.1. Company Details
    10.7.5.2. Business Overview
    10.7.5.3. Product Portfolio
    10.7.5.4. Financial Insights
    10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.5.6. SWOT Analysis
    10.7.5.7. Geographic Footprint
    10.7.6. Bristol-Myers Squibb Company
    10.7.6.1. Company Details
    10.7.6.2. Business Overview
    10.7.6.3. Product Portfolio
    10.7.6.4. Financial Insights
    10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.6.6. SWOT Analysis
    10.7.6.7. Geographic Footprint
    10.7.7. BioNTech SE
    10.7.7.1. Company Details
    10.7.7.2. Business Overview
    10.7.7.3. Product Portfolio
    10.7.7.4. Financial Insights
    10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.7.6. SWOT Analysis
    10.7.7.7. Geographic Footprint
    10.7.8. AstraZeneca
    10.7.8.1. Company Details
    10.7.8.2. Business Overview
    10.7.8.3. Product Portfolio
    10.7.8.4. Financial Insights
    10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.8.6. SWOT Analysis
    10.7.8.7. Geographic Footprint
    10.7.9. Amgen, Inc
    10.7.9.1. Company Details
    10.7.9.2. Business Overview
    10.7.9.3. Product Portfolio
    10.7.9.4. Financial Insights
    10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.9.6. SWOT Analysis
    10.7.9.7. Geographic Footprint
- 11. Methodology and Data Source
  - 11.1. Methodology/Research Approach
  - 11.2. Market Size Estimation
  - 11.3. Market Breakdown and Data Triangulation
  - 11.4. Data Source
  - 11.5. Secondary Sources
  - 11.6. Primary Sources
  - 11.7. Appendix
  - 11.8. Disclaimer
- List of Tables
  - Table 1. Global Cancer Vaccine Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 2. Global Cancer Vaccine Market Value (US$ Mn), By Technology, 2019-2033
  - Table 3. Global Cancer Vaccine Market Value (US$ Mn), By Application, 2019-2033
  - Table 4. Global Cancer Vaccine Market Value (US$ Mn), By Distribution Channel, 2019-2033
  - Table 5. Global Cancer Vaccine Market Value (US$ Mn), By Region, 2019-2033
  - Table 6. North America Cancer Vaccine Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 7. North America Cancer Vaccine Market Value (US$ Mn), By Technology, 2019-2033
  - Table 8. North America Cancer Vaccine Market Value (US$ Mn), By Application, 2019-2033
  - Table 9. North America Cancer Vaccine Market Value (US$ Mn), By Distribution Channel, 2019-2033
  - Table 10. North America Cancer Vaccine Market Value (US$ Mn), By Country, 2019-2033
  - Table 11. The US Cancer Vaccine Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 12. The US Cancer Vaccine Market Value (US$ Mn), By Technology, 2019-2033
  - Table 13. The US Cancer Vaccine Market Value (US$ Mn), By Application, 2019-2033
  - Table 14. The US Cancer Vaccine Market Value (US$ Mn), By Distribution Channel, 2019-2033
  - Table 15. Canada Cancer Vaccine Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 16. Canada Cancer Vaccine Market Value (US$ Mn), By Technology, 2019-2033
  - Table 17. Canada Cancer Vaccine Market Value (US$ Mn), By Application, 2019-2033
  - Table 18. Canada Cancer Vaccine Market Value (US$ Mn), By Distribution Channel, 2019-2033
  - Table 19. Europe Cancer Vaccine Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 20. Europe Cancer Vaccine Market Value (US$ Mn), By Technology, 2019-2033
  - Table 21. Europe Cancer Vaccine Market Value (US$ Mn), By Application, 2019-2033
  - Table 22. Europe Cancer Vaccine Market Value (US$ Mn), By Distribution Channel, 2019-2033
  - Table 23. Europe Cancer Vaccine Market Value (US$ Mn), By Country, 2019-2033
  - Table 24. Germany Cancer Vaccine Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 25. Germany Cancer Vaccine Market Value (US$ Mn), By Technology, 2019-2033
  - Table 26. Germany Cancer Vaccine Market Value (US$ Mn), By Application, 2019-2033
  - Table 27. Germany Cancer Vaccine Market Value (US$ Mn), By Distribution Channel, 2019-2033
  - Table 28. The UK Cancer Vaccine Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 29. The UK Cancer Vaccine Market Value (US$ Mn), By Technology, 2019-2033
  - Table 30. The UK Cancer Vaccine Market Value (US$ Mn), By Application, 2019-2033
  - Table 31. The UK Cancer Vaccine Market Value (US$ Mn), By Distribution Channel, 2019-2033
  - Table 32. France Cancer Vaccine Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 33. France Cancer Vaccine Market Value (US$ Mn), By Technology, 2019-2033
  - Table 34. France Cancer Vaccine Market Value (US$ Mn), By Application, 2019-2033
  - Table 35. France Cancer Vaccine Market Value (US$ Mn), By Distribution Channel, 2019-2033
  - Table 36. Spain Cancer Vaccine Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 37. Spain Cancer Vaccine Market Value (US$ Mn), By Technology, 2019-2033
  - Table 38. Spain Cancer Vaccine Market Value (US$ Mn), By Application, 2019-2033
  - Table 39. Spain Cancer Vaccine Market Value (US$ Mn), By Distribution Channel, 2019-2033
  - Table 40. Italy Cancer Vaccine Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 41. Italy Cancer Vaccine Market Value (US$ Mn), By Technology, 2019-2033
  - Table 42. Italy Cancer Vaccine Market Value (US$ Mn), By Application, 2019-2033
  - Table 43. Italy Cancer Vaccine Market Value (US$ Mn), By Distribution Channel, 2019-2033
  - Table 44. Russia Cancer Vaccine Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 45. Russia Cancer Vaccine Market Value (US$ Mn), By Technology, 2019-2033
  - Table 46. Russia Cancer Vaccine Market Value (US$ Mn), By Application, 2019-2033
  - Table 47. Russia Cancer Vaccine Market Value (US$ Mn), By Distribution Channel, 2019-2033
  - Table 48. Netherland Cancer Vaccine Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 49. Netherland Cancer Vaccine Market Value (US$ Mn), By Technology, 2019-2033
  - Table 50. Netherland Cancer Vaccine Market Value (US$ Mn), By Application, 2019-2033
  - Table 51. Netherland Cancer Vaccine Market Value (US$ Mn), By Distribution Channel, 2019-2033
  - Table 52. Rest of Europe Cancer Vaccine Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 53. Rest of Europe Cancer Vaccine Market Value (US$ Mn), By Technology, 2019-2033
  - Table 54. Rest of Europe Cancer Vaccine Market Value (US$ Mn), By Application, 2019-2033
  - Table 55. Rest of Europe Cancer Vaccine Market Value (US$ Mn), By Distribution Channel, 2019-2033
  - Table 56. Asia Pacific Cancer Vaccine Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 57. Asia Pacific Cancer Vaccine Market Value (US$ Mn), By Technology, 2019-2033
  - Table 58. Asia Pacific Cancer Vaccine Market Value (US$ Mn), By Application, 2019-2033
  - Table 59. Asia Pacific Cancer Vaccine Market Value (US$ Mn), By Distribution Channel, 2019-2033
  - Table 60. Asia Pacific Cancer Vaccine Market Value (US$ Mn), By Country, 2019-2033
  - Table 61. China Cancer Vaccine Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 62. China Cancer Vaccine Market Value (US$ Mn), By Technology, 2019-2033
  - Table 63. China Cancer Vaccine Market Value (US$ Mn), By Application, 2019-2033
  - Table 64. China Cancer Vaccine Market Value (US$ Mn), By Distribution Channel, 2019-2033
  - Table 65. India Cancer Vaccine Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 66. India Cancer Vaccine Market Value (US$ Mn), By Technology, 2019-2033
  - Table 67. India Cancer Vaccine Market Value (US$ Mn), By Application, 2019-2033
  - Table 68. India Cancer Vaccine Market Value (US$ Mn), By Distribution Channel, 2019-2033
  - Table 69. Japan Cancer Vaccine Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 70. Japan Cancer Vaccine Market Value (US$ Mn), By Technology, 2019-2033
  - Table 71. Japan Cancer Vaccine Market Value (US$ Mn), By Application, 2019-2033
  - Table 72. Japan Cancer Vaccine Market Value (US$ Mn), By Distribution Channel, 2019-2033
  - Table 73. South Korea Cancer Vaccine Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 74. South Korea Cancer Vaccine Market Value (US$ Mn), By Technology, 2019-2033
  - Table 75. South Korea Cancer Vaccine Market Value (US$ Mn), By Application, 2019-2033
  - Table 76. South Korea Cancer Vaccine Market Value (US$ Mn), By Distribution Channel, 2019-2033
  - Table 77. Australia Cancer Vaccine Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 78. Australia Cancer Vaccine Market Value (US$ Mn), By Technology, 2019-2033
  - Table 79. Australia Cancer Vaccine Market Value (US$ Mn), By Application, 2019-2033
  - Table 80. Australia Cancer Vaccine Market Value (US$ Mn), By Distribution Channel, 2019-2033
  - Table 81. New Zealand Cancer Vaccine Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 82. New Zealand Cancer Vaccine Market Value (US$ Mn), By Technology, 2019-2033
  - Table 83. New Zealand Cancer Vaccine Market Value (US$ Mn), By Application, 2019-2033
  - Table 84. New Zealand Cancer Vaccine Market Value (US$ Mn), By Distribution Channel, 2019-2033
  - Table 85. Singapore Cancer Vaccine Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 86. Singapore Cancer Vaccine Market Value (US$ Mn), By Technology, 2019-2033
  - Table 87. Singapore Cancer Vaccine Market Value (US$ Mn), By Application, 2019-2033
  - Table 88. Singapore Cancer Vaccine Market Value (US$ Mn), By Distribution Channel, 2019-2033
  - Table 89. Thailand Cancer Vaccine Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 90. Thailand Cancer Vaccine Market Value (US$ Mn), By Technology, 2019-2033
  - Table 91. Thailand Cancer Vaccine Market Value (US$ Mn), By Application, 2019-2033
  - Table 92. Thailand Cancer Vaccine Market Value (US$ Mn), By Distribution Channel, 2019-2033
  - Table 93. Vietnam Cancer Vaccine Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 94. Vietnam Cancer Vaccine Market Value (US$ Mn), By Technology, 2019-2033
  - Table 95. Vietnam Cancer Vaccine Market Value (US$ Mn), By Application, 2019-2033
  - Table 96. Vietnam Cancer Vaccine Market Value (US$ Mn), By Distribution Channel, 2019-2033
  - Table 97. Rest of Asia Pacific Cancer Vaccine Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 98. Rest of Asia Pacific Cancer Vaccine Market Value (US$ Mn), By Technology, 2019-2033
  - Table 99. Rest of Asia Pacific Cancer Vaccine Market Value (US$ Mn), By Application, 2019-2033
  - Table 100. Rest of Asia Pacific Cancer Vaccine Market Value (US$ Mn), By Distribution Channel, 2019-2033
  - Table 101. Latin America Cancer Vaccine Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 102. Latin America Cancer Vaccine Market Value (US$ Mn), By Technology, 2019-2033
  - Table 103. Latin America Cancer Vaccine Market Value (US$ Mn), By Application, 2019-2033
  - Table 104. Latin America Cancer Vaccine Market Value (US$ Mn), By Distribution Channel, 2019-2033
  - Table 105. Latin America Cancer Vaccine Market Value (US$ Mn), By Country, 2019-2033
  - Table 106. Brazil Cancer Vaccine Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 107. Brazil Cancer Vaccine Market Value (US$ Mn), By Technology, 2019-2033
  - Table 108. Brazil Cancer Vaccine Market Value (US$ Mn), By Application, 2019-2033
  - Table 109. Brazil Cancer Vaccine Market Value (US$ Mn), By Distribution Channel, 2019-2033
  - Table 110. Mexico Cancer Vaccine Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 111. Mexico Cancer Vaccine Market Value (US$ Mn), By Technology, 2019-2033
  - Table 112. Mexico Cancer Vaccine Market Value (US$ Mn), By Application, 2019-2033
  - Table 113. Mexico Cancer Vaccine Market Value (US$ Mn), By Distribution Channel, 2019-2033
  - Table 114. Rest of Latin America Cancer Vaccine Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 115. Rest of Latin America Cancer Vaccine Market Value (US$ Mn), By Technology, 2019-2033
  - Table 116. Rest of Latin America Cancer Vaccine Market Value (US$ Mn), By Application, 2019-2033
  - Table 117. Rest of Latin America Cancer Vaccine Market Value (US$ Mn), By Distribution Channel, 2019-2033
  - Table 118. Middle East & Africa Cancer Vaccine Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 119. Middle East & Africa Cancer Vaccine Market Value (US$ Mn), By Technology, 2019-2033
  - Table 120. Middle East & Africa Cancer Vaccine Market Value (US$ Mn), By Application, 2019-2033
  - Table 121. Middle East & Africa Cancer Vaccine Market Value (US$ Mn), By Distribution Channel, 2019-2033
  - Table 122. Middle East & Africa Cancer Vaccine Market Value (US$ Mn), By Country, 2019-2033
  - Table 123. South Africa Cancer Vaccine Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 124. South Africa Cancer Vaccine Market Value (US$ Mn), By Technology, 2019-2033
  - Table 125. South Africa Cancer Vaccine Market Value (US$ Mn), By Application, 2019-2033
  - Table 126. South Africa Cancer Vaccine Market Value (US$ Mn), By Distribution Channel, 2019-2033
  - Table 127. Saudi Arabia Cancer Vaccine Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 128. Saudi Arabia Cancer Vaccine Market Value (US$ Mn), By Technology, 2019-2033
  - Table 129. Saudi Arabia Cancer Vaccine Market Value (US$ Mn), By Application, 2019-2033
  - Table 130. Saudi Arabia Cancer Vaccine Market Value (US$ Mn), By Distribution Channel, 2019-2033
  - Table 131. UAE Cancer Vaccine Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 132. UAE Cancer Vaccine Market Value (US$ Mn), By Technology, 2019-2033
  - Table 133. UAE Cancer Vaccine Market Value (US$ Mn), By Application, 2019-2033
  - Table 134. UAE Cancer Vaccine Market Value (US$ Mn), By Distribution Channel, 2019-2033
  - Table 135. Rest of Middle East & Africa Cancer Vaccine Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 136. Rest of Middle East & Africa Cancer Vaccine Market Value (US$ Mn), By Technology, 2019-2033
  - Table 137. Rest of Middle East & Africa Cancer Vaccine Market Value (US$ Mn), By Application, 2019-2033
  - Table 138. Rest of Middle East & Africa Cancer Vaccine Market Value (US$ Mn), By Distribution Channel, 2019-2033
- List of Figures
  - Figure 1. Global Cancer Vaccine Market Snapshot: Market Value (US$ Mn), 2019-2033
  - Figure 2. Opportunity Map
  - Figure 3. Opportunity Orbit
  - Figure 4. Regional Market Share and BPS Analysis in Cancer Vaccine Market
  - Figure 5. Global Cancer Vaccine Market Analysis, By Product Type, 2019, 2023 and 2033
  - Figure 6. Global Cancer Vaccine Market Attractiveness Analysis, By Product Type
  - Figure 7. Global Cancer Vaccine Market Analysis, By Technology, 2019, 2023 and 2033
  - Figure 8. Global Cancer Vaccine Market Attractiveness Analysis, By Technology
  - Figure 9. Global Cancer Vaccine Market Analysis, By Application, 2019, 2023 and 2033
  - Figure 10. Global Cancer Vaccine Market Attractiveness Analysis, By Application
  - Figure 11. Global Cancer Vaccine Market Analysis, By Distribution Channel, 2019, 2023 and 2033
  - Figure 12. Global Cancer Vaccine Market Attractiveness Analysis, By Distribution Channel
  - Figure 13. Global Cancer Vaccine Market Analysis, By Region, 2019, 2023 and 2033
  - Figure 14. Global Cancer Vaccine Market Attractiveness Analysis, By Region
  - Figure 15. North America Cancer Vaccine Market Analysis, By Product Type, 2019, 2023 and 2033
  - Figure 16. North America Cancer Vaccine Market Attractiveness Analysis, By Product Type
  - Figure 17. North America Cancer Vaccine Market (US$ Mn), by Preventive, 2019-2033
  - Figure 18. North America Cancer Vaccine Market (US$ Mn), by Therapeutic, 2019-2033
  - Figure 19. North America Cancer Vaccine Market Analysis, By Technology, 2019, 2023 and 2033
  - Figure 20. North America Cancer Vaccine Market Attractiveness Analysis, By Technology
  - Figure 21. North America Cancer Vaccine Market (US$ Mn), by Vector-based, 2019-2033
  - Figure 22. North America Cancer Vaccine Market (US$ Mn), by Molecular-based, 2019-2033
  - Figure 23. North America Cancer Vaccine Market (US$ Mn), by Cell-based, 2019-2033
  - Figure 24. North America Cancer Vaccine Market Analysis, By Application, 2019, 2023 and 2033
  - Figure 25. North America Cancer Vaccine Market Attractiveness Analysis, By Application
  - Figure 26. North America Cancer Vaccine Market (US$ Mn), by Cervical Cancer, 2019-2033
  - Figure 27. North America Cancer Vaccine Market (US$ Mn), by Prostate Cancer, 2019-2033
  - Figure 28. North America Cancer Vaccine Market (US$ Mn), by Bladder Cancer, 2019-2033
  - Figure 29. North America Cancer Vaccine Market (US$ Mn), by Lung Cancer, 2019-2033
  - Figure 30. North America Cancer Vaccine Market (US$ Mn), by Others, 2019-2033
  - Figure 31. North America Cancer Vaccine Market Analysis, By Distribution Channel, 2019, 2023 and 2033
  - Figure 32. North America Cancer Vaccine Market Attractiveness Analysis, By Distribution Channel
  - Figure 33. North America Cancer Vaccine Market (US$ Mn), by Government & Organization Supply, 2019-2033
  - Figure 34. North America Cancer Vaccine Market (US$ Mn), by Hospitals, 2019-2033
  - Figure 35. North America Cancer Vaccine Market (US$ Mn), by Others, 2019-2033
  - Figure 36. North America Cancer Vaccine Market Analysis, By Country, 2019, 2023 and 2033
  - Figure 37. North America Cancer Vaccine Market Attractiveness Analysis, By Country
  - Figure 38. Europe Cancer Vaccine Market Analysis, By Product Type, 2019, 2023 and 2033
  - Figure 39. Europe Cancer Vaccine Market Attractiveness Analysis, By Product Type
  - Figure 40. Europe Cancer Vaccine Market (US$ Mn), by Preventive, 2019-2033
  - Figure 41. Europe Cancer Vaccine Market (US$ Mn), by Therapeutic, 2019-2033
  - Figure 42. Europe Cancer Vaccine Market Analysis, By Technology, 2019, 2023 and 2033
  - Figure 43. Europe Cancer Vaccine Market Attractiveness Analysis, By Technology
  - Figure 44. Europe Cancer Vaccine Market (US$ Mn), by Vector-based, 2019-2033
  - Figure 45. Europe Cancer Vaccine Market (US$ Mn), by Molecular-based, 2019-2033
  - Figure 46. Europe Cancer Vaccine Market (US$ Mn), by Cell-based, 2019-2033
  - Figure 47. Europe Cancer Vaccine Market Analysis, By Application, 2019, 2023 and 2033
  - Figure 48. Europe Cancer Vaccine Market Attractiveness Analysis, By Application
  - Figure 49. Europe Cancer Vaccine Market (US$ Mn), by Cervical Cancer, 2019-2033
  - Figure 50. Europe Cancer Vaccine Market (US$ Mn), by Prostate Cancer, 2019-2033
  - Figure 51. Europe Cancer Vaccine Market (US$ Mn), by Bladder Cancer, 2019-2033
  - Figure 52. Europe Cancer Vaccine Market (US$ Mn), by Lung Cancer, 2019-2033
  - Figure 53. Europe Cancer Vaccine Market (US$ Mn), by Others, 2019-2033
  - Figure 54. Europe Cancer Vaccine Market Analysis, By Distribution Channel, 2019, 2023 and 2033
  - Figure 55. Europe Cancer Vaccine Market Attractiveness Analysis, By Distribution Channel
  - Figure 56. Europe Cancer Vaccine Market (US$ Mn), by Government & Organization Supply, 2019-2033
  - Figure 57. Europe Cancer Vaccine Market (US$ Mn), by Hospitals, 2019-2033
  - Figure 58. Europe Cancer Vaccine Market (US$ Mn), by Others, 2019-2033
  - Figure 59. Europe Cancer Vaccine Market Analysis, By Country, 2019, 2023 and 2033
  - Figure 60. Europe Cancer Vaccine Market Attractiveness Analysis, By Country
  - Figure 61. Asia Pacific Cancer Vaccine Market Analysis, By Product Type, 2019, 2023 and 2033
  - Figure 62. Asia Pacific Cancer Vaccine Market Attractiveness Analysis, By Product Type
  - Figure 63. Asia Pacific Cancer Vaccine Market (US$ Mn), by Preventive, 2019-2033
  - Figure 64. Asia Pacific Cancer Vaccine Market (US$ Mn), by Therapeutic, 2019-2033
  - Figure 65. Asia Pacific Cancer Vaccine Market Analysis, By Technology, 2019, 2023 and 2033
  - Figure 66. Asia Pacific Cancer Vaccine Market Attractiveness Analysis, By Technology
  - Figure 67. Asia Pacific Cancer Vaccine Market (US$ Mn), by Vector-based, 2019-2033
  - Figure 68. Asia Pacific Cancer Vaccine Market (US$ Mn), by Molecular-based, 2019-2033
  - Figure 69. Asia Pacific Cancer Vaccine Market (US$ Mn), by Cell-based, 2019-2033
  - Figure 70. Asia Pacific Cancer Vaccine Market Analysis, By Application, 2019, 2023 and 2033
  - Figure 71. Asia Pacific Cancer Vaccine Market Attractiveness Analysis, By Application
  - Figure 72. Asia Pacific Cancer Vaccine Market (US$ Mn), by Cervical Cancer, 2019-2033
  - Figure 73. Asia Pacific Cancer Vaccine Market (US$ Mn), by Prostate Cancer, 2019-2033
  - Figure 74. Asia Pacific Cancer Vaccine Market (US$ Mn), by Bladder Cancer, 2019-2033
  - Figure 75. Asia Pacific Cancer Vaccine Market (US$ Mn), by Lung Cancer, 2019-2033
  - Figure 76. Asia Pacific Cancer Vaccine Market (US$ Mn), by Others, 2019-2033
  - Figure 77. Asia Pacific Cancer Vaccine Market Analysis, By Distribution Channel, 2019, 2023 and 2033
  - Figure 78. Asia Pacific Cancer Vaccine Market Attractiveness Analysis, By Distribution Channel
  - Figure 79. Asia Pacific Cancer Vaccine Market (US$ Mn), by Government & Organization Supply, 2019-2033
  - Figure 80. Asia Pacific Cancer Vaccine Market (US$ Mn), by Hospitals, 2019-2033
  - Figure 81. Asia Pacific Cancer Vaccine Market (US$ Mn), by Others, 2019-2033
  - Figure 82. Asia Pacific Cancer Vaccine Market Analysis, By Country, 2019, 2023 and 2033
  - Figure 83. Asia Pacific Cancer Vaccine Market Attractiveness Analysis, By Country
  - Figure 84. Latin America Cancer Vaccine Market Analysis, By Product Type, 2019, 2023 and 2033
  - Figure 85. Latin America Cancer Vaccine Market Attractiveness Analysis, By Product Type
  - Figure 86. Latin America Cancer Vaccine Market (US$ Mn), by Preventive, 2019-2033
  - Figure 87. Latin America Cancer Vaccine Market (US$ Mn), by Therapeutic, 2019-2033
  - Figure 88. Latin America Cancer Vaccine Market Analysis, By Technology, 2019, 2023 and 2033
  - Figure 89. Latin America Cancer Vaccine Market Attractiveness Analysis, By Technology
  - Figure 90. Latin America Cancer Vaccine Market (US$ Mn), by Vector-based, 2019-2033
  - Figure 91. Latin America Cancer Vaccine Market (US$ Mn), by Molecular-based, 2019-2033
  - Figure 92. Latin America Cancer Vaccine Market (US$ Mn), by Cell-based, 2019-2033
  - Figure 93. Latin America Cancer Vaccine Market Analysis, By Application, 2019, 2023 and 2033
  - Figure 94. Latin America Cancer Vaccine Market Attractiveness Analysis, By Application
  - Figure 95. Latin America Cancer Vaccine Market (US$ Mn), by Cervical Cancer, 2019-2033
  - Figure 96. Latin America Cancer Vaccine Market (US$ Mn), by Prostate Cancer, 2019-2033
  - Figure 97. Latin America Cancer Vaccine Market (US$ Mn), by Bladder Cancer, 2019-2033
  - Figure 98. Latin America Cancer Vaccine Market (US$ Mn), by Lung Cancer, 2019-2033
  - Figure 99. Latin America Cancer Vaccine Market (US$ Mn), by Others, 2019-2033
  - Figure 100. Latin America Cancer Vaccine Market Analysis, By Distribution Channel, 2019, 2023 and 2033
  - Figure 101. Latin America Cancer Vaccine Market Attractiveness Analysis, By Distribution Channel
  - Figure 102. Latin America Cancer Vaccine Market (US$ Mn), by Government & Organization Supply, 2019-2033
  - Figure 103. Latin America Cancer Vaccine Market (US$ Mn), by Hospitals, 2019-2033
  - Figure 104. Latin America Cancer Vaccine Market (US$ Mn), by Others, 2019-2033
  - Figure 105. Latin America Cancer Vaccine Market Analysis, By Country, 2019, 2023 and 2033
  - Figure 106. Latin America Cancer Vaccine Market Attractiveness Analysis, By Country
  - Figure 107. Middle East & Africa Cancer Vaccine Market Analysis, By Product Type, 2019, 2023 and 2033
  - Figure 108. Middle East & Africa Cancer Vaccine Market Attractiveness Analysis, By Product Type
  - Figure 109. Middle East & Africa Cancer Vaccine Market (US$ Mn), by Preventive, 2019-2033
  - Figure 110. Middle East & Africa Cancer Vaccine Market (US$ Mn), by Therapeutic, 2019-2033
  - Figure 111. Middle East & Africa Cancer Vaccine Market Analysis, By Technology, 2019, 2023 and 2033
  - Figure 112. Middle East & Africa Cancer Vaccine Market Attractiveness Analysis, By Technology
  - Figure 113. Middle East & Africa Cancer Vaccine Market (US$ Mn), by Vector-based, 2019-2033
  - Figure 114. Middle East & Africa Cancer Vaccine Market (US$ Mn), by Molecular-based, 2019-2033
  - Figure 115. Middle East & Africa Cancer Vaccine Market (US$ Mn), by Cell-based, 2019-2033
  - Figure 116. Middle East & Africa Cancer Vaccine Market Analysis, By Application, 2019, 2023 and 2033
  - Figure 117. Middle East & Africa Cancer Vaccine Market Attractiveness Analysis, By Application
  - Figure 118. Middle East & Africa Cancer Vaccine Market (US$ Mn), by Cervical Cancer, 2019-2033
  - Figure 119. Middle East & Africa Cancer Vaccine Market (US$ Mn), by Prostate Cancer, 2019-2033
  - Figure 120. Middle East & Africa Cancer Vaccine Market (US$ Mn), by Bladder Cancer, 2019-2033
  - Figure 121. Middle East & Africa Cancer Vaccine Market (US$ Mn), by Lung Cancer, 2019-2033
  - Figure 122. Middle East & Africa Cancer Vaccine Market (US$ Mn), by Others, 2019-2033
  - Figure 123. Middle East & Africa Cancer Vaccine Market Analysis, By Distribution Channel, 2019, 2023 and 2033
  - Figure 124. Middle East & Africa Cancer Vaccine Market Attractiveness Analysis, By Distribution Channel
  - Figure 125. Middle East & Africa Cancer Vaccine Market (US$ Mn), by Government & Organization Supply, 2019-2033
  - Figure 126. Middle East & Africa Cancer Vaccine Market (US$ Mn), by Hospitals, 2019-2033
  - Figure 127. Middle East & Africa Cancer Vaccine Market (US$ Mn), by Others, 2019-2033
  - Figure 128. Middle East & Africa Cancer Vaccine Market Analysis, By Country, 2019, 2023 and 2033
  - Figure 129. Middle East & Africa Cancer Vaccine Market Attractiveness Analysis, By Country
- Treos Bio Limited
- Sanofi Company Profile
- Moderna, Inc.
- Ferring B.V.
- Dynavax Technologies.
- Bristol-Myers Squibb Company
- BioNTech SE
- AstraZeneca Plc Company Profile
- Amgen, Inc.
Settings

Related Reports

Our Clients

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)